MedTrace Logo

Measuring Urinary Nano Particles and Metallic Compounds in TCC Patients

NCT02811952 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-10-14

No results posted yet for this study

Summary

In many of urothelial carcinoma patients, one does not find common risk factors such as smoking. The medical center is located in an industrial city with known air and water pollution. The investigators decided to check the presence of nano particles and traces of metals in urinary samples of patients known and suspected for urothelial carcinoma and compare the results to both cystoscopic and cytological findings. The patients will fill a validated epidemiological respiratory disease survey and the results will be compared to a control group.

Conditions

Interventions

OTHER

without intervention

without intervention

Sponsors & Collaborators

  • Carmel Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-23
Primary Completion
2020-07-31
Completion
2021-01-01

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02811952 on ClinicalTrials.gov